ADVENT at ERS-ISIAN 2025

Join experts Vibeke Backer, MD, DMSC, and Sietze Reitsma, MD, at an educational symposium involving a comprehensive exploration of the type 2 inflammation and its pivotal role in the pathogenesis and management of CRSwNP.

DMSc, MD

Vibeke Backer +1 more

See post-event materials

Past event

20June2025

Location

HUNGEXPO

Budapest Hungary

Symposium Details

June 24

Type 2 Inflammation and Disease Control in CRSwNP: Current Perspectives and Future Directions

In this educational presentation, Profs. Vibeke Backer and Sietze Reitsma cover key aspects of type 2 inflammation and its role in the pathogenesis and management of CRSwNP and practical strategies for optimizing disease control and improving patient outcomes.

See On-Demand materials

Agenda

Welcome & Introductions

Vibeke Backer

Type 2 Inflammation: Links With Severe/Uncontrolled CRSwNP

Vibeke Backer

From Treatable Traits to Understanding Disease Control in CRSwNP

Sietze Reitsma

Patient Perceptions of Disease Control in CRSwNP

Sietze Reitsma

Audience Q&A

All Faculty

Location

HUNGEXPO

Budapest Hungary

Speakers

Pulmonology

DMSc, MD

Vibeke Backer

Chief Respiratory Physician, Department of ENT and Centre for Physical Activity Research | Rigshospitalet, Copenhagen, Denmark

Rhinology

MD, PhD

Sietze Reitsma

ENT and Rhinologist at the University Medical Centres in Amsterdam | Professor at the Department of Otorhinolaryngology and Head and Neck Surgery | University of Amsterdam

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: IsraelChange country/region